A "body armor" of leukemia cutis

Am J Hematol. 2015 Aug;90(8):751. doi: 10.1002/ajh.23948. Epub 2015 Feb 25.

Authors

Nico A F Janssen^{1

2}, Konnie M Hebeda³, Wendy B C Stevens¹, Walter J F M van der Velden¹

Affiliations

¹ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
² Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.

PMID: 25611338
DOI: 10.1002/ajh.23948

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / therapeutic use
Cell Movement
Daunorubicin / therapeutic use
Fatal Outcome
Female
Hematopoietic Stem Cell Transplantation*
Humans
Idarubicin / therapeutic use
Leukemia, Myeloid, Acute / complications
Leukemia, Myeloid, Acute / pathology*
Leukemia, Myeloid, Acute / therapy
Recurrence
Remission Induction
Sarcoma, Myeloid / complications
Sarcoma, Myeloid / pathology*
Sarcoma, Myeloid / therapy
Skin / pathology*
Skin Neoplasms / complications
Skin Neoplasms / pathology*
Skin Neoplasms / therapy
Transplantation, Homologous

Substances

Antineoplastic Agents
Idarubicin
Daunorubicin